Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Maximus, Inc.(MMS) | 500,304 | 768,825 | +268,521 | $43.19M | $49.28M | 7.10% | +$6.10M |
| Waystar Holding Corp.(WAY) | 613,725 | 1,642,236 | +1,028,511 | $20.10M | $39.59M | 5.71% | +$19.49M |
| ICON Public Limited CompanySHS(ICLR) | 127,202 | 306,358 | +179,156 | $23.18M | $33.90M | 4.89% | +$10.72M |
| Cencora Inc | 15,900 | 100,894 | +84,994 | $5.37M | $31.69M | 4.57% | +$26.32M |
| Dianthus Therapeutics, Inc.(DNTH) | 474,503 | 370,045 | -104,458 | $19.55M | $31.05M | 4.48% | +$11.50M |
| Anteris Technologies Global Corp.(AVR) | 1,874,641 | 5,382,965 | +3,508,324 | $9.35M | $29.88M | 4.31% | +$20.52M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 674,759 | +674,759 | $0 | $27.20M | 3.92% | +$27.20M |
| LivaNova PLCSHS(LIVN) | 322,382 | 421,615 | +99,233 | $19.84M | $26.80M | 3.86% | +$6.96M |
| Tyra Biosciences, Inc.(TYRA) | 526,002 | 605,439 | +79,437 | $13.83M | $23.19M | 3.34% | +$9.36M |
| Celcuity Inc.(CELC) | 477,067 | 193,843 | -283,224 | $47.58M | $22.13M | 3.19% | -$25.46M |
| GSK plcADR(GSK) | 0 | 385,879 | +385,879 | $0 | $21.30M | 3.07% | +$21.30M |
| ANI Pharmaceuticals, Inc.(ANIP) | 87,272 | 265,543 | +178,271 | $6.89M | $20.42M | 2.94% | +$13.53M |
| Abbott Laboratories | 0 | 186,574 | +186,574 | $0 | $19.16M | 2.76% | +$19.16M |
| Embecta Corp.(EMBC) | 0 | 1,847,850 | +1,847,850 | $0 | $16.33M | 2.35% | +$16.33M |
| ABIVAX Société AnonymeADS(ABVX) | 43,124 | 135,800 | +92,676 | $5.82M | $15.12M | 2.18% | +$9.31M |
| Vir Biotechnology, Inc.(VIR) | 478,343 | 1,498,620 | +1,020,277 | $2.88M | $13.43M | 1.94% | +$10.54M |
| Haemonetics Corporation(HAE) | 92,631 | 220,672 | +128,041 | $7.42M | $12.44M | 1.79% | +$5.01M |
| Sionna Therapeutics, Inc.(SION) | 0 | 294,340 | +294,340 | $0 | $11.80M | 1.70% | +$11.80M |
| SanofiADR(SNY) | 971,686 | 239,671 | -732,015 | $47.09M | $11.55M | 1.66% | -$35.54M |
| Rapport Therapeutics, Inc.(RAPP) | 185,265 | 366,809 | +181,544 | $5.62M | $11.48M | 1.65% | +$5.86M |
| Teleflex Incorporated(TFX) | 86,876 | 94,800 | +7,924 | $10.60M | $11.34M | 1.63% | +$736.7K |
| BioMarin Pharmaceutical Inc.(BMRN) | 232,688 | 194,226 | -38,462 | $13.83M | $10.97M | 1.58% | -$2.86M |
| Cross Ctry Healthcare Inc | 1,068,821 | 1,098,393 | +29,572 | $8.66M | $10.32M | 1.49% | +$1.67M |
| Protara Therapeutics, Inc.(TARA) | 1,715,394 | 1,969,839 | +254,445 | $9.14M | $10.26M | 1.48% | +$1.12M |
| Structure Therapeutics IncADS | 201,500 | 209,093 | +7,593 | $14.01M | $10.08M | 1.45% | -$3.94M |
| Biohaven Ltd.(BHVN) | 1,244,764 | 1,163,926 | -80,838 | $14.05M | $9.85M | 1.42% | -$4.21M |
| Monopar Therapeutics Inc.(MNPR) | 0 | 173,506 | +173,506 | $0 | $9.51M | 1.37% | +$9.51M |
| EyePoint, Inc.(EYPT) | 0 | 721,785 | +721,785 | $0 | $9.30M | 1.34% | +$9.30M |
| Crinetics Pharmaceuticals In | 124,841 | 249,887 | +125,046 | $5.81M | $9.08M | 1.31% | +$3.26M |
| Edgewise Therapeutics, Inc.(EWTX) | 237,481 | 268,986 | +31,505 | $5.89M | $8.47M | 1.22% | +$2.58M |
| COMPASS Pathways plcADS(CMPS) | 0 | 1,506,525 | +1,506,525 | $0 | $8.33M | 1.20% | +$8.33M |
| Ocular Therapeutix, Inc.(OCUL) | 0 | 968,597 | +968,597 | $0 | $8.20M | 1.18% | +$8.20M |
| Aquestive Therapeutics Inc | 993,095 | 1,922,887 | +929,792 | $6.42M | $7.98M | 1.15% | +$1.56M |
| Relmada Therapeutics, Inc.(RLMD) | 0 | 965,000 | +965,000 | $0 | $6.72M | 0.97% | +$6.72M |
| Oruka Therapeutics, Inc.(ORKA) | 118,126 | 132,496 | +14,370 | $3.58M | $6.50M | 0.94% | +$2.92M |
| Zenas BioPharma, Inc.(ZBIO) | 0 | 331,730 | +331,730 | $0 | $6.49M | 0.93% | +$6.49M |
| Bright Minds Biosciences Inc.(DRUG) | 81,883 | 86,083 | +4,200 | $6.39M | $6.28M | 0.91% | -$108.7K |
| QuidelOrtho Corporation(QDEL) | 0 | 359,011 | +359,011 | $0 | $5.90M | 0.85% | +$5.90M |
| Zimmer Biomet Holdings, Inc.(ZBH) | 385,642 | 62,613 | -323,029 | $34.68M | $5.66M | 0.82% | -$29.02M |
| Replimune Group, Inc.(REPL) | 0 | 720,036 | +720,036 | $0 | $5.51M | 0.79% | +$5.51M |
| Organon & Co.(OGN) | 3,421,765 | 865,908 | -2,555,857 | $24.53M | $5.19M | 0.75% | -$19.35M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 1,078,965 | +1,078,965 | $0 | $4.47M | 0.64% | +$4.47M |
| Disc Medicine, Inc.(IRON) | 57,586 | 65,203 | +7,617 | $4.57M | $4.17M | 0.60% | -$403.8K |
| PMV Pharmaceuticals, Inc.(PMVP) | 2,636,548 | 3,076,580 | +440,032 | $3.30M | $3.81M | 0.55% | +$519.3K |
| Immunome, Inc.(IMNM) | 0 | 165,110 | +165,110 | $0 | $3.61M | 0.52% | +$3.61M |
| Integra LifeSciences Holdings Corporation(IART) | 0 | 383,140 | +383,140 | $0 | $3.61M | 0.52% | +$3.61M |
| Savara Inc.(SVRA) | 613,888 | 613,888 | 0 | $3.70M | $3.35M | 0.48% | -$349.9K |
| Proqr Therapeutics N VSHS EURO SHS EURO | 2,164,181 | 1,954,715 | -209,466 | $4.37M | $3.17M | 0.46% | -$1.21M |
| Shoulder Innovations, Inc.(SI) | 227,971 | 210,641 | -17,330 | $3.26M | $3.06M | 0.44% | -$199.4K |
| Ovid Therapeutics Inc.(OVID) | 1,427,495 | 1,252,381 | -175,114 | $2.33M | $2.78M | 0.40% | +$453.5K |
| Kymera Therapeutics, Inc.(KYMR) | 32,235 | 32,235 | 0 | $2.51M | $2.68M | 0.39% | +$176.6K |
| Aligos Therapeutics, Inc.(ALGS) | 335,937 | 327,237 | -8,700 | $3.13M | $2.43M | 0.35% | -$699.6K |
| Context Therapeutics Inc.(CNTX) | 1,341,636 | 917,922 | -423,714 | $1.97M | $2.40M | 0.35% | +$432.8K |
| An2 Therapeutics Inc | 0 | 657,200 | +657,200 | $0 | $2.25M | 0.32% | +$2.25M |
| Serina Therapeutics, Inc.(SER) | 0 | 1,000,000 | +1,000,000 | $0 | $1.94M | 0.28% | +$1.94M |
| iBio, Inc.(IBIO) | 740,000 | 904,268 | +164,268 | $1.43M | $1.72M | 0.25% | +$289.9K |
| Adagio Medical Holdings, Inc.(ADGM) | 1,288,461 | 1,288,461 | 0 | $1.34M | $1.48M | 0.21% | +$141.7K |
| Xilio Therapeutics, Inc.(XLO) | 0 | 152,464 | +152,464 | $0 | $1.28M | 0.18% | +$1.28M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 130,628 | 130,628 | 0 | $1.64M | $1.17M | 0.17% | -$466.3K |
| Hyperfine, Inc.CL A(HYPR) | 2,000,000 | 1,000,000 | -1,000,000 | $1.96M | $1.08M | 0.16% | -$878.6K |
| Senseonics Holdings, Inc.(SENS) | 115,784 | 115,784 | 0 | $639.1K | $771.1K | 0.11% | +$132.0K |
| Foghorn Therapeutics Inc.(FHTX) | 122,889 | 122,889 | 0 | $663.6K | $587.4K | 0.08% | -$76.2K |
| Terns Pharmaceuticals Inc | 10,100 | 10,100 | 0 | $408.0K | $532.5K | 0.08% | +$124.4K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 40,000 | 40,000 | 0 | $630.8K | $505.2K | 0.07% | -$125.6K |
| TELA Bio, Inc.(TELA) | 636,300 | 636,300 | 0 | $750.8K | $394.5K | 0.06% | -$356.3K |
| Neuroone Med Technologies Co COM NEW | 1,140,040 | 496,614 | -643,426 | $864.1K | $385.6K | 0.06% | -$478.5K |
| Boundless Bio, Inc.(BOLD) | 163,679 | 163,679 | 0 | $196.4K | $180.0K | 0.03% | -$16.4K |
| Nyxoah S ASHS SHS | 50,839 | 50,839 | 0 | $233.9K | $148.4K | 0.02% | -$85.4K |
| Modular Medical, Inc.(MODD) | 0 | 26,190 | +26,190 | $0 | $138.3K | 0.02% | +$138.3K |
| Erasca, Inc.(ERAS) | 0 | 5,000 | +5,000 | $0 | $80.9K | 0.01% | +$80.9K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 400,000 | 400,000 | 0 | $7.2K | $7.0K | 0.00% | -$180 |
| Humacyte, Inc.W EXP 08 27 202(HUMA) | 49,998 | 49,998 | 0 | $4.9K | $4.6K | 0.00% | -$303 |
| Simulations Plus Inc | 0 | 200 | +200 | $0 | $2.4K | 0.00% | +$2.4K |
| Alkermes plcSHS(ALKS) | 95,353 | 0 | -95,353 | $2.67M | $0 | — | -$2.67M |
| Avalo Therapeutics, Inc.(AVTX) | 72,173 | 0 | -72,173 | $1.31M | $0 | — | -$1.31M |
| BrightSpring Health Services, Inc.(BTSG) | 308,010 | 0 | -308,010 | $11.53M | $0 | — | -$11.53M |
| Centene Corporation(CNC) | 274,350 | 0 | -274,350 | $11.29M | $0 | — | -$11.29M |
| Charles River Laboratories International, Inc.(CRL) | 54,985 | 0 | -54,985 | $10.97M | $0 | — | -$10.97M |
| The Cigna Group(CI) | 172,203 | 0 | -172,203 | $47.40M | $0 | — | -$47.40M |
| Fulcrum Therapeutics, Inc.(FULC) | 382,000 | 0 | -382,000 | $4.32M | $0 | — | -$4.32M |
| IDEAYA Biosciences, Inc.(IDYA) | 75,730 | 0 | -75,730 | $2.62M | $0 | — | -$2.62M |
| Kenvue Inc.(KVUE) | 1,465,442 | 0 | -1,465,442 | $25.28M | $0 | — | -$25.28M |
| McKesson Corporation(MCK) | 6,400 | 0 | -6,400 | $5.25M | $0 | — | -$5.25M |
| Modular Med Inc | 785,824 | 0 | -785,824 | $286.1K | $0 | — | -$286.1K |
| Nextcure Inc | 10,940 | 0 | -10,940 | $155.2K | $0 | — | -$155.2K |
| Ventyx Biosciences Inc | 387,751 | 0 | -387,751 | $3.50M | $0 | — | -$3.50M |
| Xilio Therapeutics, Inc.(XLO) | 2,134,537 | 0 | -2,134,537 | $1.37M | $0 | — | -$1.37M |